Literature DB >> 24768231

Is myomectomy in women aged 45 years and older an effective option?

Da Hee Kim1, Mi-La Kim2, Taejong Song1, Mi Kyoung Kim1, Bo Sung Yoon1, Seok Ju Seong1.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the recurrence and reoperation rate after myomectomy in women aged 45 years and older, who want to preserve their uterus. STUDY
DESIGN: We performed a retrospective review of women aged ≥45 years that underwent myomectomy between January 2000 and December 2010. The inclusion criteria were premenopausal status, myomectomy through abdominal or laparoscopic surgery, and at least 12 months interval from surgery. The clinical outcomes, including symptomatic change, recurrence of myoma on transvaginal ultrasonography (TVS), and reoperation data were collected and analyzed.
RESULTS: A total 92 patients were included in this study. The median age of the patient was 47 years (range 45-53 years), and the median follow-up duration was 30.5 months (range 12-95 months). On follow-up TVS, the recurrence of myoma was detected in 20 of 82 (24.4%) patients. Ten (10.9%) patients were not subjected to follow-up TVS. However, during their pelvic examination, the uterus was normal size, and all the 10 patients experienced symptomatic improvement and none of them needed additional surgical management. Using the Kaplan-Meier method, the cumulative recurrence rate at 36 months after myomectomy was calculated as 17.1%. Three patients underwent hysterectomy during the follow-up periods, and only one underwent hysterectomy due to myoma. The overall reoperation rate after myomectomy in this age group was 3.3%, and the reoperation for myoma rate was only 1.1%.
CONCLUSION: Considering the natural regression of myoma after menopause, myomectomy might be an effective option for women aged 45 years and older, who want to preserve their uterus.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Myomectomy; Recurrence rate; Reoperation rate

Mesh:

Year:  2014        PMID: 24768231     DOI: 10.1016/j.ejogrb.2014.04.006

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  The effects of menopausal uterine fibroids on the prognosis of endometrium cancer.

Authors:  Önder Sakin; Ramazan Denizli; Zehra Meltem Pirimoğlu; Ali Doğukan Anğın; Muzaffer Seyhan Çıkman; Gökhan Gülyaşar
Journal:  Turk J Obstet Gynecol       Date:  2020-07-29

2.  Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.

Authors:  Jung-Yun Lee; Hyun Soo Kim; Eun Ji Nam; Sang Wun Kim; Sunghoon Kim; Young Tae Kim
Journal:  BMC Cancer       Date:  2016-08-23       Impact factor: 4.430

3.  Increased Risk of Venous Thromboembolism in Women with Uterine Leiomyoma: A Nationwide, Population-Based Case-Control Study.

Authors:  Hung-Kai Huang; Chew-Teng Kor; Ching-Pei Chen; Hung-Te Chen; Po-Ta Yang; Chen-Dao Tsai; Ching-Hui Huang
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.